Novel centrosome-associated protein and applications thereof

A medicinal product, which comprises an active component selected from the group consisting of:

• a) a protein, ASAP, selected from the group consisting of a human protein of sequence SEQ ID NO:
• 1 and the proteins for which the sequence exhibits at least 80% identity or at least 90% similarity, with the entire sequence SEQ ID NO:
• 1,
• b) a peptide of at least 10 consecutive amino acids of the protein defined in a),
• c) a monoclonal or polyclonal antibody capable of specifically recognizing the protein defined in a) or the peptide defined in b),
• d) a polynucleotide encoding the protein defined in a) or the peptide defined in b), or a polynucleotide that is antisense to the preceding polynucleotide,
• e) a polynucleotide fragment of at least 15 consecutive nucleotides of the polynucleotide defined in d) or a fragment that is antisense to the preceding fragment,
• f) an expression vector comprising the polynucleotide defined in d) or the fragment defined in e), and
• g) a host cell transformed with the polynucleotide defined in d), the fragment defined in e) or the vector defined in f).